Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France.

Fiche publication


Date publication

avril 2021

Journal

ESMO open

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CONROY Thierry, Pr COUTANT Charles, Dr GENTIL Julie, Pr MERROUCHE Yacine, Pr PIVOT Xavier, Dr DEBREUVE-THERESETTE Adeline


Tous les auteurs :
Blay JY, Boucher S, Le Vu B, Cropet C, Chabaud S, Perol D, Barranger E, Campone M, Conroy T, Coutant C, De Crevoisier R, Debreuve-Theresette A, Delord JP, Fumoleau P, Gentil J, Gomez F, Guerin O, Jaffré A, Lartigau E, Lemoine C, Mahe MA, Mahon FX, Mathieu-Daude H, Merrouche Y, Penault-Llorca F, Pivot X, Soria JC, Thomas G, Vera P, Vermeulin T, Viens P, Ychou M, Beaupere S

Résumé

The impact of the first coronavirus disease 2019 (COVID-19) wave on cancer patient management was measured within the nationwide network of the Unicancer comprehensive cancer centers in France.

Mots clés

COVID-19, cancer, delay, diagnosis, treatment

Référence

ESMO Open. 2021 Apr 17;6(3):100134